On December 5, 2024, the board of Gavi, the Vaccine Alliance approved a series of decisions that will help countries to sustain their own immunization programs and close equity gaps in the most vulnerable communities. A two-day meeting hosted by the Indonesian government saw members take stock of recent historic strides made across Gavi’s core programmatic priorities: In 2024, Gavi supported the introduction of malaria vaccination programs, exceeding the forecasted target of 15 countries. Furthermore, they witnessed an unprecedented scale-up of HPV vaccination campaigns in 2024, with more girls reached with Gavi support than in any other year in history.
At the same time, 2024 saw a rise in the number of zero-dose children in Gavi countries, largely driven by ongoing humanitarian and health crises, an increase in disease outbreaks driven partly by climate change and macroeconomic challenges in some Gavi supported countries, placing at risk their abilities to sustain immunization programs.
Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.